Jae Hyun Lee
Subscribe to Jae Hyun Lee's PostsJae Hyun Lee is a member of the Healthcare Practice Group. He focuses his practice on healthcare mergers and acquisitions as well as regulatory and compliance matters. Read Jae's full bio here.
This Week in 340B: June 28 – July 1, 2024
By Emily Jane Cook, Bryan Frederick, Jae Hyun Lee, Patrick Moore and Kelsey Reinhardt on Jul 3, 2024
Posted In 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of...
Continue Reading
CMS Issues FAQs to Aid Pharmacies in Preparing for Medicare Part B Coverage of PrEP Medications
By Gregory E. Fosheim, Monica Wallace, Emily Jane Cook and Jae Hyun Lee on Jun 26, 2024
Posted In Hospitals & Health Systems, Life Sciences, Managed Care
As we previously advised, the Centers for Medicare & Medicaid Services (CMS) is preparing to issue a national coverage determination (NCD) for pre-exposure prophylaxis (PrEP) using antiretroviral drugs to prevent HIV under Medicare Part B. In response to questions from stakeholders, CMS released FAQs on June 25, 2024, to guide pharmacies through certain enrollment and...
Continue Reading
This Week in 340B: June 18 – 24, 2024
By Emily Jane Cook, Reuben Bank, Bryan Frederick, Jae Hyun Lee, Patrick Moore and Kelsey Reinhardt on Jun 25, 2024
Posted In 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of...
Continue Reading
This Week in 340B: June 4 – 10, 2024
By Emily Jane Cook, Jae Hyun Lee, Patrick Moore and Kelsey Reinhardt on Jun 11, 2024
Posted In 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of...
Continue Reading
This Week in 340B: May 21 – 27, 2024
By Emily Jane Cook, Bryan Frederick, Jae Hyun Lee and Kelsey Reinhardt on May 31, 2024
Posted In 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of...
Continue Reading
This Week in 340B: May 14 – 20, 2024
By Emily Jane Cook, Bryan Frederick, Jae Hyun Lee and Patrick Moore on May 21, 2024
Posted In 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of...
Continue Reading
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B
By Monica Wallace, Emily Jane Cook, Gregory E. Fosheim and Jae Hyun Lee on Apr 25, 2024
Posted In Life Sciences
On April 15, the Centers for Medicare & Medicaid Services (CMS) released a fact sheet on the potential national coverage determination (NCD) for pre-exposure prophylaxis (PrEP) using antiretroviral drugs to prevent HIV. CMS did not announce any coverage changes in the fact sheet but is providing advance information to avoid any possible disruptions to beneficiaries...
Continue Reading
This Week in 340B: February 21 – 26, 2024
By Emily Jane Cook, Reuben Bank, Bryan Frederick, Jae Hyun Lee, Patrick Moore and Kelsey Reinhardt on Feb 26, 2024
Posted In 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of...
Continue Reading
HRSA Issues Notice Confirming 340B Registration Requirement
By Emily Jane Cook, Steven Schnelle and Jae Hyun Lee on Oct 27, 2023
Posted In 340B
On October 26, the Health Resources and Services Administration (HRSA) published a Federal Register notice addressing the use of 340B drugs at off-campus hospital outpatient locations that have not yet appeared on a filed Medicare cost report. These locations are known as “unregistered child sites.” In the notice, HRSA maintains that its prior policy allowing...
Continue Reading
